Amundi
RDY icon

Amundi’s Dr. Reddy's Laboratories RDY Stock Holding History

Amundi’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$623K Hold
45,000
– – ﹤0.01% 1463
2025
Q4 		$632K Sell
45,000
-53,450
-54% -$750K ﹤0.01% 1392
2025
Q3 		$1.39M Hold
98,450
– – ﹤0.01% 1109
2025
Q2 		$1.46M Hold
98,450
– – ﹤0.01% 1138
2025
Q1 		$1.3M Hold
98,450
– – ﹤0.01% 1259
2024
Q4 		$1.56M Buy
98,450
+23,500
+31% +$353K ﹤0.01% 1272
2024
Q3 		$1.18M Sell
74,950
-415
-0.6% -$6.68K ﹤0.01% 1254
2024
Q2 		$1.15M Sell
75,365
-4,310
-5% -$61.8K ﹤0.01% 1189
2024
Q1 		$1.13M Sell
79,675
-406,035
-84% -$5.93M ﹤0.01% 1260
2023
Q4 		$6.74M Buy
485,710
+293,390
+153% +$3.92M ﹤0.01% 932
2023
Q3 		$2.56M Buy
192,320
+47,500
+33% +$643K ﹤0.01% 1118
2023
Q2 		$1.81M Buy
144,820
+10,500
+8% +$123K ﹤0.01% 1178
2023
Q1 		$1.56M Sell
134,320
-46,000
-26% -$497K ﹤0.01% 1193
2022
Q4 		$1.9M Buy
180,320
+61,500
+52% +$663K ﹤0.01% 1193
2022
Q3 		$1.28M Sell
118,820
-188,500
-61% -$2.01M ﹤0.01% 1207
2022
Q2 		$3.52M Buy
307,320
+64,000
+26% +$696K ﹤0.01% 979
2022
Q1 		$2.76M Sell
243,320
-88,455
-27% -$1M ﹤0.01% 1075
2021
Q4 		$4.21M Sell
331,775
-91,500
-22% -$1.15M ﹤0.01% 1037
2021
Q3 		$5.51M Buy
423,275
+92,000
+28% +$1.23M ﹤0.01% 989
2021
Q2 		$4.87M Buy
+331,275
New +$4.63M ﹤0.01% 1013

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $70.2B AUM 29.99% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $345M AUM 10.59% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Amundi's RDY Position: Q1 2026 in Review

Amundi held its Dr. Reddy's Laboratories (RDY) position steady in Q1 2026 at 45,000 shares worth $623K. The position accounts for ﹤0.01% of the portfolio, ranked #1463.

Amundi first reported a position in RDY in Q2 2021 and has held it in 20 quarters since. The position peaked at $6.74M in Q4 2023. 247 funds tracked by Wall St. Rank hold RDY as of Q1 2026.

  • Amundi held 45,000 shares of Dr. Reddy's Laboratories worth $623K as of Q1 2026.
  • Amundi left its Dr. Reddy's Laboratories share count unchanged in Q1 2026.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Amundi's portfolio in Q1 2026, its #1463 holding.
  • Amundi first reported a position in Dr. Reddy's Laboratories in Q2 2021 and has held it in 20 quarters since.
  • Amundi's Dr. Reddy's Laboratories position peaked at $6.74M in Q4 2023.
  • 247 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2026.

Based on Amundi's 13F filing for Q1 2026, filed 18 May 2026.